# OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.T

> **NIH NIH N01** · THE EMMES COMPANY, LLC · 2022 · $1,350,572

## Abstract

OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100).

This contract is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction. This study will continue to build the evidence-basis for better treatment of opioid misuse and addiction in order to stem the national opioid public health crisis.

## Key facts

- **NIH application ID:** 10667369
- **Project number:** 75N95019D00013-P00002-759502000002-1
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** PAUL VANVELDHUISEN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,350,572
- **Award type:** —
- **Project period:** 2020-03-01 → 2026-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10667369

## Citation

> US National Institutes of Health, RePORTER application 10667369, OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.T (75N95019D00013-P00002-759502000002-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10667369. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*